Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen 1 Year Total Returns (Daily) : 55.82% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 55.82% |
| August 20, 2026 | 54.22% |
| August 19, 2026 | 59.56% |
| August 18, 2026 | 56.39% |
| August 17, 2026 | 50.90% |
| August 14, 2026 | 55.50% |
| August 13, 2026 | 55.82% |
| August 12, 2026 | 62.00% |
| August 11, 2026 | 59.29% |
| August 10, 2026 | 58.51% |
| August 07, 2026 | 62.77% |
| August 06, 2026 | 59.49% |
| August 05, 2026 | 55.49% |
| August 04, 2026 | 57.68% |
| August 03, 2026 | 52.95% |
| July 31, 2026 | 58.55% |
| July 30, 2026 | 64.19% |
| July 29, 2026 | 63.59% |
| July 28, 2026 | 59.04% |
| July 27, 2026 | 52.17% |
| July 24, 2026 | 52.49% |
| July 23, 2026 | 53.17% |
| July 22, 2026 | 54.67% |
| July 21, 2026 | 65.60% |
| July 20, 2026 | 59.97% |
| Date | Value |
|---|---|
| July 17, 2026 | 60.07% |
| July 16, 2026 | 62.63% |
| July 15, 2026 | 54.70% |
| July 14, 2026 | 44.20% |
| July 13, 2026 | 55.75% |
| July 10, 2026 | 47.16% |
| July 09, 2026 | 49.53% |
| July 08, 2026 | 49.01% |
| July 07, 2026 | 58.07% |
| July 06, 2026 | 56.89% |
| July 02, 2026 | 62.26% |
| July 01, 2026 | 61.25% |
| June 30, 2026 | 72.04% |
| June 29, 2026 | 71.82% |
| June 26, 2026 | 70.21% |
| June 25, 2026 | 58.64% |
| June 24, 2026 | 58.02% |
| June 23, 2026 | 58.06% |
| June 22, 2026 | 57.20% |
| June 18, 2026 | 55.35% |
| June 17, 2026 | 56.98% |
| June 16, 2026 | 49.28% |
| June 15, 2026 | 52.04% |
| June 12, 2026 | 51.20% |
| June 11, 2026 | 50.28% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Ionis Pharmaceuticals, Inc. | 38.18% |
| AbbVie, Inc. | 30.40% |
| Gilead Sciences, Inc. | 29.10% |
| Vertex Pharmaceuticals, Inc. | 37.89% |
| Amgen, Inc. | 53.88% |